Your new experience awaits. Try the new design now and help us make it even better

BRIEF RESEARCH REPORT article

Front. Vet. Sci.

Sec. Veterinary Pharmacology and Toxicology

This article is part of the Research TopicNatural Compounds in Veterinary Therapeutics - volume IIView all articles

The preventive effect of chlorogenic acid on cisplatin-induced acute kidney injury induced in mice1

Provisionally accepted
Hong Ya  ZhengHong Ya Zheng1Yichang  DuanYichang Duan1Zheng  ZhongZheng Zhong1Yanzhu  ZhuYanzhu Zhu2Wei  NiuWei Niu3Caoxing  HuangCaoxing Huang4Baishuang  YinBaishuang Yin3*
  • 1Heilongjiang Bayi Agricultural University, Daqing, China
  • 2Jilin Agricultural Science and Technology College, Jilin, China
  • 3Jilin Agricultural Science and Technology University, Jilin, China
  • 4Nanjing Forestry University, Nanjing, China

The final, formatted version of the article will be published soon.

Abstract :Acute kidney injury (AKI) is a prevalent clinical syndrome. Chlorogenic acid (CGA) is a natural polyphenol and has antioxidant and anti-inflammatory properties. Sixty male Kunming mice were randomly assigned to six groups: Control (CON), Cisplatin (CIS), CGA, CIS + CGA, CIS + Furosemide (FUR), and FUR group. Kidney injury markers, inflammatory indicators, antioxidant enzyme activities, oxidative product, antioxidant proteins, kidney morphology were evaluated by ELISA, Histology, and Western blot. The results showed that preventive CGA supplementation significantly reduced the contents of Creatinine (Cr), BUN, KIM-1, and MDA, restored the enzymatic activities of SOD, GSH-Px, CAT, and T-AOC vitality. The expression of Nrf2 and GCLC proteins were increased, whereas the expression of Keap1 protein was decreased. IL-1β, IL-2 and IL-6 levels were reduced, while IL-10 levels were elevated. These findings indicated that preventive CGA supplementation effectively mitigates CIS-induced AKI by enhancing antioxidant capacity, attenuating inflammatory responses, and ameliorating kidney structural damage.

Keywords: Acute Kidney Injury, antioxidant capacity, Chlorogenic Acid, Cisplatin, Mice

Received: 09 Dec 2025; Accepted: 26 Jan 2026.

Copyright: © 2026 Zheng, Duan, Zhong, Zhu, Niu, Huang and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Baishuang Yin

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.